LNZ100 is a single-use, once-daily eye drop containing aceclidine, a small molecule acetylcholine receptor agonist that causes miosis. The NDA is supported by data from the CLARITY phase 3 program ...

Myasthenia gravis treatment aims to minimize the effects of muscle weakness due to an immune process. It includes medications ...

In particular, the finding that acetylcholine-receptor antagonists have an antiproliferative effect on neural stem cells has important implications for the understanding and treatment of Alzheimer ...